Bracco Suisse SA
Bracco Suisse SA is a Originators company based in Plan-les-Ouates (Geneva) recorded by Swissmedic as the authorisation holder for 10 human medicines. That places it 146 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Plan-les-Ouates |
| Canton | Geneva |
| Authorisation holder | Yes |
| Medicines | 10 |
| Founded | Not available |
| Employees | 51-200 |
| Parent group | Bracco S.p.A. |
| Activity | Not available |
| Website | bracco.com |
Medicines authorised in Switzerland
Bracco Suisse SA is recorded by Swissmedic as the authorisation holder for 10 human medicines. The table shows 10 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
10 of 10 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Cardiogen-82 | 62332 | A | V09GX04 | 2013-05-17 |
| Iomeron 250 mg/ml | 53255 | B | - | 1997-06-04 |
| Iomeron 300 mg/ml | 53602 | B | V08AB10 | 1997-06-04 |
| Iopamiro 300 | 44140 | B | V08AB04 | 1982-12-20 |
| MultiHance 0.05 mmol/ml | 56212 | B | - | 2003-06-23 |
| ProHance 0.5 mmol/ml | 52273 | B | V08CA04 | 1995-08-29 |
| ProHance 0.5 mmol/ml | 52599 | B | V08CA04 | 2000-12-15 |
| SonoVue 8 µL/mL | 56032 | B | V08DA05 | 2002-08-07 |
| Vueway | 69760 | B | V08CA12 | 2024-03-28 |
| Vueway | 69761 | B | V08CA12 | 2024-03-28 |
Frequently asked questions
How many medicines does Bracco Suisse SA have authorised in Switzerland?
Bracco Suisse SA is recorded by Swissmedic as the authorisation holder for 10 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Bracco Suisse SA based?
The Swiss location recorded for Bracco Suisse SA is Plan-les-Ouates, Geneva.
Is Bracco Suisse SA a Swissmedic authorisation holder?
Yes. Bracco Suisse SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.